GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (XPAR:ALMKT) » Definitions » Quick Ratio

Mauna Kea Technologies (XPAR:ALMKT) Quick Ratio : 0.66 (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Mauna Kea Technologies's quick ratio for the quarter that ended in Jun. 2024 was 0.66.

Mauna Kea Technologies has a quick ratio of 0.66. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Mauna Kea Technologies's Quick Ratio or its related term are showing as below:

XPAR:ALMKT' s Quick Ratio Range Over the Past 10 Years
Min: 0.28   Med: 2.01   Max: 5.32
Current: 0.66

During the past 13 years, Mauna Kea Technologies's highest Quick Ratio was 5.32. The lowest was 0.28. And the median was 2.01.

XPAR:ALMKT's Quick Ratio is ranked worse than
86.77% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 1.92 vs XPAR:ALMKT: 0.66

Mauna Kea Technologies Quick Ratio Historical Data

The historical data trend for Mauna Kea Technologies's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Quick Ratio Chart

Mauna Kea Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 1.88 2.13 0.94 0.43

Mauna Kea Technologies Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 0.94 0.74 0.43 0.66

Competitive Comparison of Mauna Kea Technologies's Quick Ratio

For the Medical Devices subindustry, Mauna Kea Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mauna Kea Technologies's Quick Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Quick Ratio falls into.



Mauna Kea Technologies Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Mauna Kea Technologies's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(14.327-2.863)/26.74
=0.43

Mauna Kea Technologies's Quick Ratio for the quarter that ended in Jun. 2024 is calculated as

Quick Ratio (Q: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(10.761-3.216)/11.426
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mauna Kea Technologies  (XPAR:ALMKT) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Mauna Kea Technologies Quick Ratio Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies Headlines

No Headlines